Find a Tender Service

NP92619 ERT Medicines

The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")

Awarded
goods
Framework agreement
Scotland

This tender has closed

The submission deadline for this contract has passed. There may be more active goods tenders from The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS"), and hundreds more across the UK public sector.

Key details

Region
Edinburgh
Delivery: Scotland
Contract value
£20,056,400ex VAT
Submissions closed
Not stated by buyer
Published
18 July 2023

Procurement

Contract period
1 October 2019 - 30 September 2023
4 years
CPV classifications
  • 33600000 Pharmaceutical products

What happened

The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS") awarded this contract to Aventis Pharma Ltd Trading As Sanofi worth £20,056,400 on 7 Aug 2019. The contract runs until 30 Sept 2023.

Description

The following Framework Agreements have been extended and are for the supply of the following ERT Medicines to NHS Scotland: NP92619 (a) Laronidase - Aldurazyme® NP92619 (b) Imiglucerase - Cerezyme® NP92619 (c) Agalsidase Beta - Fabrazyme® NP92619 (d) Alglucosidase Alfa - Myozyme®.

Awarded supplier

Supplier
Aventis Pharma Ltd Trading As Sanofi
Award value
£20,056,400
Award date
7 August 2019

Contact

Address
Gyle Square (NSS Head Office), 1 South Gyle Crescent, Edinburgh, EH12 9EB
Contact name
Michelle Semple

Identifiers

Buyer reference
NP92619 (a-d)
Notice ID
020567-2023
OCID
ocds-h6vhtk-03e2c5

Explore related tenders

External ID: fts-ocds-h6vhtk-03e2c5 • Added 20 August 2026